A. Niederman

发表

A randomized comparison of the effects of gradual prolonged versus standard primary balloon inflation on early and late outcome. Results of a multicenter clinical trial. Perfusion Balloon Catheter Study Group.

D. Ricci, M. Knudtson, D. Kereiakes, 1994, Circulation.

Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study

K. Mahaffey, R. Becker, R. Harrington, 2009, The Lancet.

Vasopeptidase inhibition with omapatrilat in chronic heart failure: acute and long-term hemodynamic and neurohumoral effects.

E. Fleck, M. Komajda, J. Hanyok, 2002, Journal of the American College of Cardiology.

Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: Results of the TIMI 31 trial

S. Murphy, C. McCabe, C. Gibson, 2006, Journal of Thrombosis and Thrombolysis.

Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first".

M. Cohen, D. Moliterno, D. Kereiakes, 2000, The Journal of invasive cardiology.

Fatal aortic rupture during percutaneous balloon valvuloplasty for valvular aortic stenosis.

S. King, G. Roubin, N. Lembo, 1987, The American journal of cardiology.

Effects of omapatrilat on hemodynamics and safety in patients with heart failure.

M. Klapholz, M. Bilsker, J. Heywood, 2001, The American journal of cardiology.

Plasma Angiotensin-Converting Enzyme Activity and Carotid Wall Thickening

R. Califf, D. Paterson, E. Topol, 2005 .

Abstract 5638: Autologous CD34+ Cell Therapy for Refractory Angina: 12 Month Results of the Phase II ACT34-CMI Study

A. Yeung, R. Strumpf, T. Henry, 2009 .

A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction.

R. Roberts, C. O'connor, T. Henry, 2011, American heart journal.

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).

E. Topol, A. Lincoff, R. Harrington, 2004, The American journal of cardiology.

Tear or dissection after coronary angioplasty. Morphologic correlates of an ischemic complication.

J. Douglas, S. King, G. Roubin, 1989, Circulation.

Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial).

Theodore A Bass, D. Angiolillo, M. Tannenbaum, 2008, The American journal of cardiology.

Evaluation of enalapril combined with diltiazem ER in patients with stage 3-4 essential hypertension.

H. Gavras, R. Goldstein, T. Marbury, 1998, Clinical and experimental hypertension.

Clinical Utility of Long‐Term Enalapril/Diltiazem ER in Stage 3–4 Essential Hypertension

H. Gavras, R. Goldstein, T. Marbury, 1997, Journal of clinical pharmacology.

Evaluation of indapamide 1.25 mg once daily in elderly patients with mild to moderate hypertension

J. Blumenthal, K. Lasseter, S. Rosenblatt, 1997, Journal of Human Hypertension.

Morphologic Correlates of an Ischemic Complication

J. Douglas, S. King, G. Roubin, 2005 .

MARVEL-1; A Double-Blind, Randomized, Controlled, Multicenter Study to Assess The Safety And Cardiovascular Effects of Myocell™ Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s)

R. Roberts, C. O'connor, T. Henry, 2009 .

PexeLizumab for Acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: A randomized controlled trial

Ajai Kumar Jain, P. Armstrong, F. Van de Werf, 2007 .